Search Results

There are 11846 results for: content related to: Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis

  1. The systemic safety of fexofenadine HCl

    Clinical & Experimental Allergy

    Volume 29, Issue S3, July 1999, Pages: 163–170, J. Mason, R. Reynolds and N. Rao

    Article first published online : 10 SEP 2009, DOI: 10.1046/j.1365-2222.1999.0290s3163.x

  2. An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers

    Clinical & Experimental Allergy

    Volume 32, Issue 1, January 2002, Pages: 133–139, I. Hindmarch, Z. Shamsi and S. Kimber

    Article first published online : 28 FEB 2002, DOI: 10.1046/j.0022-0477.2001.01245.x

  3. A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

    Clinical & Experimental Allergy

    Volume 32, Issue 1, January 2002, Pages: 126–132, A. M. Wilson, L. C. Orr, W. J. R. Coutie, E. J. Sims and B. J. Lipworth

    Article first published online : 28 FEB 2002, DOI: 10.1046/j.0022-0477.2001.01252.x

  4. Cardiovascular safety of fexofenadine HCl

    Clinical & Experimental Allergy

    Volume 29, Issue S3, July 1999, Pages: 212–216, C. Pratt, A. M. Brown, D. Rampe, J. Mason, T. Russell, R. Reynolds and R. Ahlbrandt

    Article first published online : 10 SEP 2009, DOI: 10.1046/j.1365-2222.1999.0290s3212.x

  5. Suppressive activity of fexofenadine hydrochloride on metalloproteinase production from nasal fibroblasts in vitro

    Clinical & Experimental Allergy

    Volume 34, Issue 12, December 2004, Pages: 1890–1898, K. Asano, K.-I. Kanai and H. Suzaki

    Article first published online : 13 DEC 2004, DOI: 10.1111/j.1365-2222.2004.02127.x

  6. Association of HLA-DRB1*07 and DRB1*04 to citrus red mite (Panonychus citri) and house dust mite sensitive asthma

    Clinical & Experimental Allergy

    Volume 30, Issue 11, November 2000, Pages: 1568–1575, S.-H. Cho, Y.-K. Kim, H.-B. Oh, J.-W. Jung, J.-W. Son, M.-H. Lee, H.-S. Jee, Y.-Y. Kim and K.-U. Min

    Article first published online : 5 SEP 2008, DOI: 10.1046/j.1365-2222.2000.00915.x

  7. Emerging role of antileukotriene therapy in allergic rhinitis

    Clinical & Experimental Allergy

    Volume 31, Issue 12, December 2001, Pages: 1813–1821, B. J. Lipworth

    Article first published online : 20 DEC 2001, DOI: 10.1046/j.1365-2222.2001.01202.x

  8. Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity

    Clinical & Experimental Allergy

    Volume 29, Issue S3, July 1999, Pages: 182–189, M. Taglialatela, P. Castaldo, A. Pannaccione, G. Giorgio, A. Genovese, G. Marone and L. Annunziato

    Article first published online : 10 SEP 2009, DOI: 10.1046/j.1365-2222.1999.0290s3182.x

  9. Clinical assessment of antihistamines in rhinitis

    Clinical & Experimental Allergy

    Volume 29, Issue S3, July 1999, Pages: 77–81, G. K. Scadding

    Article first published online : 10 SEP 2009, DOI: 10.1046/j.1365-2222.1999.00018.x-i1

  10. Rapid polarization of Th2 cells during induction of antigen-specific IgE antibodies in vitro

    Clinical & Experimental Allergy

    Volume 30, Issue 9, September 2000, Pages: 1298–1306, Åkesson, Ingvarsson, Brady, Moynagh and Borrebaeck

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2222.2000.00912.x

  11. Non-cardiac adverse effects of antihistamines (H1-receptor antagonists)

    Clinical & Experimental Allergy

    Volume 29, Issue S3, July 1999, Pages: 125–132, F. E. R. Simons

    Article first published online : 10 SEP 2009, DOI: 10.1046/j.1365-2222.1999.0290s3125.x

  12. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects

    Clinical & Experimental Allergy

    Volume 32, Issue 4, April 2002, Pages: 489–498, R. Leurs, M. K. Church and M. Taglialatela

    Article first published online : 21 NOV 2002, DOI: 10.1046/j.0954-7894.2002.01314.x

  13. Inhibition of the histamine-induced weal and flare response: a valid surrogate measure for antihistamine clinical efficacy?

    Clinical & Experimental Allergy

    Volume 37, Issue 3, March 2007, Pages: 400–414, P. Devillier and J. Bousquet

    Article first published online : 9 MAR 2007, DOI: 10.1111/j.1365-2222.2007.02662.x

  14. Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment

    Clinical & Experimental Allergy

    Volume 30, Issue 10, October 2000, Pages: 1423–1429, M. T. Mellerup, G. W. Hahn, L. K. Poulsen and H.-J. Malling

    Article first published online : 5 APR 2002, DOI: 10.1046/j.1365-2222.2000.00910.x

  15. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis

    Clinical & Experimental Allergy

    Volume 34, Issue 4, April 2004, Pages: 646–649, D. K. C. Lee, R. D. Gray, F. M. Robb, S. Fujihara and B. J. Lipworth

    Article first published online : 1 MAR 2004, DOI: 10.1111/j.1365-2222.2004.1903.x

  16. Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis

    Clinical & Experimental Allergy

    Volume 34, Issue 4, April 2004, Pages: 650–653, D. K. C. Lee, M. Gardiner, K. Haggart, S. Fujihara and B. J. Lipworth

    Article first published online : 1 MAR 2004, DOI: 10.1111/j.1365-2222.2004.1904.x

  17. The transmembrane protein occludin of epithelial tight junctions is a functional target for serine peptidases from faecal pellets of Dermatophagoides pteronyssinus

    Clinical & Experimental Allergy

    Volume 31, Issue 2, February 2001, Pages: 279–294, H. Wan, H. L. Winton, C. Soeller, G. W. Taylor, D. C. Gruenert, P. J. Thompson, M. B. Cannell, G. A. Stewart, D. R. Garrod and C. Robinson

    Article first published online : 7 JUL 2008, DOI: 10.1046/j.1365-2222.2001.00970.x

  18. You have free access to this content
    BSACI guidelines for the management of chronic urticaria and angio-oedema

    Clinical & Experimental Allergy

    Volume 37, Issue 5, May 2007, Pages: 631–650, R. J. Powell, G. L. Du Toit, N. Siddique, S. C. Leech, T. A. Dixon, A. T. Clark, R. Mirakian, S. M. Walker, P. A. J. Huber and S. M. Nasser

    Article first published online : 22 MAR 2007, DOI: 10.1111/j.1365-2222.2007.02678.x

  19. The metabolism of antihistamines and drug interactions: the role of cytochrome P450 enzymes

    Clinical & Experimental Allergy

    Volume 29, Issue S3, July 1999, Pages: 116–124, A. G. Renwick

    Article first published online : 10 SEP 2009, DOI: 10.1046/j.1365-2222.1999.0290s3116.x

  20. Reduced IFNγ production in response to IL-12 stimulation and/or reduced IL-12 production in atopic patients

    Clinical & Experimental Allergy

    Volume 30, Issue 9, September 2000, Pages: 1250–1256, Matsui, Kaneko, Teramoto, Fukao, Inoue, Kasahara, Takemura, Seishima and Kondo

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2222.2000.00931.x